DENTSPLY SIRONA Director Acquires Shares via RSU Dividends
DENTSPLY SIRONA Inc.
Subscribe to track XRAY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
DENTSPLY SIRONA Director Acquires Shares via RSU Dividends
Company: DENTSPLY SIRONA Inc. (XRAY) Form: 4 | Filed: 2025-10-15 Significance: Low
Insider: Vergis Janet S. Title: null | Relationship: Director
Transaction: • Type: Grant • Shares: 179.449 • Price: $0.00 • Value: $0 • Owned After: 44,300.167
Key Insight: This is a routine, non-discretionary acquisition of shares representing dividends on existing Restricted Stock Units (RSUs). It does not signal a new investment decision by the insider.
Market Context: The transaction is an automatic part of the director's compensation structure and has no cash value, indicating low market significance.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: DENTSPLY SIRONA Inc. (XRAY)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director of DENTSPLY SIRONA Inc. acquired 179.449 shares at no cost as part of a dividend reinvestment on existing Restricted Stock Units (RSUs). This is a non-discretionary transaction with no market signal.
- Market Impact: Neutral. This type of transaction is routine and does not reflect a new investment decision by the insider, so no market reaction is expected.
Company Information
| Field | Value |
|---|---|
| Company | DENTSPLY SIRONA Inc. |
| Ticker Symbol | XRAY |
| CIK | 0000818479 |
| Industry | DENTAL EQUIPMENT & SUPPLIES [3843] |
Insider Information
| Field | Value |
|---|---|
| Name | Vergis Janet S. |
| CIK | 0001590794 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-10 |
| Transaction Code | A (Award) |
| Security Type | Common Stock |
| Shares Involved | 179.449 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 44,300.167 |
| Ownership Type | Direct |
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is an automatic acquisition of shares through dividend reinvestment on previously granted RSUs, not a new open-market purchase. It carries a $0 price and is part of a pre-existing compensation plan, thus providing no new information about the insider's sentiment.
Volume & Sentiment
- Expected Volume Impact: None. The transaction is not an open-market trade and will not affect trading volume.
- Sentiment Indicator: Neutral. This is a procedural transaction, not an indicator of bullish or bearish sentiment from the insider.
Investment Insights
Positive Market Indicators
- N/A. This filing does not provide any positive market indicators as it's a non-discretionary transaction.
Risk Factors
- N/A. This filing does not present any new risk factors.
Key Takeaways
- Non-Discretionary Transaction: The acquisition was automatic, stemming from dividends on existing RSUs.
- No New Insider Sentiment: This filing does not reflect a change in the director's view of the company's future prospects.
- Low Significance: With a total value of $0, the transaction is immaterial from a market analysis perspective.
Contextual Analysis
Timing Significance
- The timing of this transaction is tied to the dividend payment schedule for the underlying RSUs and is not indicative of any strategic decision by the insider based on market conditions.
Transaction Context
- The filing's footnote clarifies the nature of the transaction: "Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis." This confirms the acquisition is a feature of the director's compensation package.
Company Context
- DENTSPLY SIRONA (XRAY) operates in the dental equipment and supplies industry. This filing is a routine corporate governance event and should be viewed in the context of the company's standard executive compensation practices.
Risk Assessment
Risk Level: Low
Risk Factors
- This specific filing introduces no new risks. Investors should focus on the company's fundamental performance, industry trends, and overall market conditions.
Market Considerations
- The primary takeaway for investors is to differentiate between discretionary insider trades (buys/sells) and non-discretionary ones (like this RSU dividend). Only the former typically provides a signal.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-15 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.